These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8388207)

  • 21. Breast cancer incidence and hormone replacement therapy: results from the MISSION study, prospective phase.
    Espié M; Daures JP; Chevallier T; Mares P; Micheletti MC; De Reilhac P
    Gynecol Endocrinol; 2007 Jul; 23(7):391-7. PubMed ID: 17701770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Quantitative evaluation of the cardiovascular risk associated with hormone substitution therapy during menopause].
    Scarabin PY; Plu-Bureau G
    Arch Mal Coeur Vaiss; 1993 Feb; 86(2):243-8. PubMed ID: 8363427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of estrogens as a risk factor for stroke in postmenopausal women.
    Rosenberg SH; Fausone V; Clark R
    West J Med; 1980 Oct; 133(4):292-6. PubMed ID: 7347044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cause-specific mortality in women receiving hormone replacement therapy.
    Schairer C; Adami HO; Hoover R; Persson I
    Epidemiology; 1997 Jan; 8(1):59-65. PubMed ID: 9116097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study.
    Wilson PW; Garrison RJ; Castelli WP
    N Engl J Med; 1985 Oct; 313(17):1038-43. PubMed ID: 2995808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A nationwide cohort study on the incidence of meningioma in women using postmenopausal hormone therapy in Finland.
    Korhonen K; Auvinen A; Lyytinen H; Ylikorkala O; Pukkala E
    Am J Epidemiol; 2012 Feb; 175(4):309-14. PubMed ID: 22287638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement.
    Falkeborn M; Persson I; Adami HO; Bergström R; Eaker E; Lithell H; Mohsen R; Naessén T
    Br J Obstet Gynaecol; 1992 Oct; 99(10):821-8. PubMed ID: 1419993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen replacement therapy and fibrocystic breast disease.
    Pastides H; Najjar MA; Kelsey JL
    Am J Prev Med; 1987; 3(5):282-6. PubMed ID: 2838061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone replacement therapy and breast cancer mortality in Swedish women: results after adjustment for 'healthy drug-user' effect.
    Yuen J; Persson I; Bergkvist L; Hoover R; Schairer C; Adami HO
    Cancer Causes Control; 1993 Jul; 4(4):369-74. PubMed ID: 8394149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies.
    Carrasquilla GD; Frumento P; Berglund A; Borgfeldt C; Bottai M; Chiavenna C; Eliasson M; Engström G; Hallmans G; Jansson JH; Magnusson PK; Nilsson PM; Pedersen NL; Wolk A; Leander K
    PLoS Med; 2017 Nov; 14(11):e1002445. PubMed ID: 29149179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study.
    Naessén T; Persson I; Adami HO; Bergström R; Bergkvist L
    Ann Intern Med; 1990 Jul; 113(2):95-103. PubMed ID: 2360759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiovascular diseases and hormone replacement therapy in females].
    Szücs J
    Orv Hetil; 1995 Feb; 136(8 Suppl 1):455-7. PubMed ID: 7877817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hormone replacement therapy].
    Tanaka K; Honjo H
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():696-700. PubMed ID: 11347156
    [No Abstract]   [Full Text] [Related]  

  • 35. [Menopausal hormone replacement therapy and prevention of neurologic complications].
    Lopes P; Mensier A; Laurent FX; Besse O
    Contracept Fertil Sex; 1995 May; 23(5):319-22. PubMed ID: 7613577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone replacement therapy and risk of non-fatal stroke.
    Pedersen AT; Lidegaard O; Kreiner S; Ottesen B
    Lancet; 1997 Nov; 350(9087):1277-83. PubMed ID: 9357407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of estrogen on cardiovascular disease. Prospective studies: The Framingham Study.
    Wilson PW
    Postgrad Med; 1989 Apr; Spec No():51-3; discussion 89-90. PubMed ID: 2542911
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of estradiol-progestin therapy associates with increased risk for uterine sarcomas.
    Jaakkola S; Lyytinen HK; Pukkala E; Ylikorkala O
    Gynecol Oncol; 2011 Aug; 122(2):260-3. PubMed ID: 21531011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Menopause and the epidemiology of cardiovascular disease in women.
    Perlman J; Wolf P; Finucane F; Madans J
    Prog Clin Biol Res; 1989; 320():283-312. PubMed ID: 2602441
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased incidence of symptomatic cholesterol cholelithiasis in perimenopausal women receiving estrogen replacement therapy: a retrospective study.
    Honoré LH
    J Reprod Med; 1980 Oct; 25(4):187-90. PubMed ID: 6253639
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.